NasdaqGS:GILDBiotechs
Gilead Sciences (GILD) Starts AI Biomarker Research Partnership For Oncology
Gilead Sciences (NasdaqGS:GILD) announced a new AI powered translational research collaboration with Nucleai focused on biomarker discovery and precision oncology development.
The partnership uses Nucleai's AI driven tissue analytics platform to support Gilead's global antibody drug conjugate clinical programs.
The companies aim to standardize biomarker analyses in clinical trials to support more tailored cancer treatments and potential improvements in clinical outcomes.
This type of AI...